Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis. (Q47391384)

15 January 2018

title

Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis. (English)

1 reference

15 January 2018

1 reference

5

Matt van de Rijn

1 reference

15 January 2018

C. Blake Gilks

4

object named as

C Blake Gilks

1 reference

15 January 2018

author name string

Emanuela D'Angelo

1

1 reference

15 January 2018

Inigo Espinosa

2

1 reference

15 January 2018

Rola Ali

3

1 reference

15 January 2018

Cheng-Han Lee

6

1 reference

15 January 2018

Jaime Prat

7

1 reference

15 January 2018

language of work or name

English

0 references

publication date

12 February 2011

1 reference

15 January 2018

published in

Gynecologic Oncology

1 reference

15 January 2018

volume

121

1 reference

15 January 2018

issue

2

1 reference

15 January 2018

page(s)

328-333

1 reference

15 January 2018

Uterine leiomyosarcoma: analysis of treatment failures and survival

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Uterine leiomyosarcoma: present management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Prognostic factors and outcome in women with uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Putting tumours in context

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Tissue microarrays (TMAs) for high-throughput molecular pathology research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Uterine sarcomas: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.022

10.1016/J.YGYNO.2011.01.022

7 January 2021

Identifiers

DOI

1 reference

15 January 2018

PubMed ID

21316747

1 reference

15 January 2018